IgG and IgA response to SARS-CoV-2 in serum and saliva samples from infected healthcare workers who suffered from relatively mild disease

IgG and IgA response to SARS-CoV-2 in serum and saliva samples from infected healthcare workers who suffered from relatively mild disease - Investigation into the antibody response to SARS-CoV-2 infection

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON49759

Enrollment

Registered

2020-04-15

Start date

2020-04-14

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 new coronavirus

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Healthcare workers with confirmed SARS-CoV-2 infection.

Exclusion criteria

Exclusion criteria: unable to give written informed consent; health care workers that are involved in the design and execution of this study.

Design outcomes

Primary

Measure	Time frame
IgG and IgA titers	—

Secondary

Measure	Time frame
sensitivity of Euroimmun assay, the presence of virus neutralizing antibodies	—

Countries

Netherlands

Outcome results